Nevertheless, the findings further our understanding of the long-standing debate about the role of BP in migraine susceptibility, reveal the prominent genetic-based role of DBP in migraine susceptibility, and identify shared genetic components including ADRA2B, all of which may provide insight into future migraine therapies. The gene discussed is ADRA2B; the disease is migraine disorder.